Dose requirements of ICI 35,868 (Propofol, ‘Diprivan’) in a new formulation for induction of anaesthesia
- 1 December 1984
- journal article
- Published by Wiley in Anaesthesia
- Vol. 39 (12) , 1168-1171
- https://doi.org/10.1111/j.1365-2044.1984.tb06425.x
Abstract
In order to avoid Cremophor-related reactions and reduce the incidence of pain on injection, diisopropylphenol (ICI 35,868; propofol) has been reformulated as an emulsion. One hundred and fifteen patients received an induction dose of propofol in the new formulation. The dose required to induce anaesthesia in 95% of healthy, unpremedicated patients was 2.5 mg/kg. Induction was associated with a degree of cardiovascular and respiratory depression. There were no adverse reactions although there were a number of minor side-effects. The incidence of pain on injection was low (3%) and the overall quality of induction was assessed as good or adequate in 92% of patients.Keywords
This publication has 17 references indexed in Scilit:
- FAT EMULSION AS A VECHICLE FOR DIAZEPAM. A STUDY OF 9492 PATIENTSBritish Journal of Anaesthesia, 1983
- An adverse reaction to the administration of disoprofol (Diprivan)Anaesthesia, 1982
- Dose‐response relationship for disoprofol (ICI 35868; Diprivan)Anaesthesia, 1981
- Synthesis, biological evaluation, and preliminary structure-activity considerations of a series of alkylphenols as intravenous anesthetic agentsJournal of Medicinal Chemistry, 1980
- ICI 35868 (Diprivan): a new intravenous induction agent.Anaesthesia, 1980
- ICI 35868 (Diprivan): a new intravenous anaestheticAnaesthesia, 1980
- Suspected anaphylactic reaction to Cremophor EL.BMJ, 1980
- COMPLEMENT-MEDIATED REACTIONS TO DIAZEPAM WITH CREMOPHOR AS SOLVENT (STESOLID MR)British Journal of Anaesthesia, 1980
- ADVERSE REACTIONS TO INTRAVENOUS ANAESTHETICS: A Survey of 100 ReportsBritish Journal of Anaesthesia, 1975